175 related articles for article (PubMed ID: 6684458)
21. The effect of cytidine-diphosphate choline (CDP-choline) on brain lipid changes during aging.
De Medio GE; Trovarelli G; Piccinin GL; Porcellati G
J Neurosci Res; 1984; 11(1):49-58. PubMed ID: 6708133
[TBL] [Abstract][Full Text] [Related]
22. Study of the effects of oral administration of CDP-choline on open-field behaviour under conditions of chronic hypoxia.
Hamdorf G; Cervós-Navarro J
Arzneimittelforschung; 1990 May; 40(5):519-22. PubMed ID: 2383294
[TBL] [Abstract][Full Text] [Related]
23. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
24. High-resolution autoradiography in mouse brain 24 h after radiolabelled CDP-choline administration.
Romero A; Serratosa J; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1056-8. PubMed ID: 6684466
[TBL] [Abstract][Full Text] [Related]
25. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
26. High-resolution autoradiography in mouse brain and cerebellum 10 days after radiolabelled CDP-choline administration.
Romero A; Serratosa J; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1058-60. PubMed ID: 6684467
[TBL] [Abstract][Full Text] [Related]
27. Increase of survival time in experimental hypoxia by cytidine diphosphate choline.
Hamdorf G; Cervós-Navarro J; Müller R
Arzneimittelforschung; 1992 Apr; 42(4):421-4. PubMed ID: 1642665
[TBL] [Abstract][Full Text] [Related]
28. Treatment of chronic dyskinesia with CDP-choline.
Arranz J; Ganoza C
Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
[TBL] [Abstract][Full Text] [Related]
29. Cerebral subcellular distribution of CDP-choline and/or its metabolites after oral administration of methyl-14C CDP-choline.
Aguilar J; Giménez R; Bachs O; Enrich C; Agut J
Arzneimittelforschung; 1983; 33(7A):1051-3. PubMed ID: 6225438
[TBL] [Abstract][Full Text] [Related]
30. The influence of systemic factors on acrylamide-induced changes in brain, nerve, and other tissues.
Lapin EP; Maker HS; Weissbarth S; Weiss C; Lehrer GM
J Neurosci Res; 1984; 11(4):395-404. PubMed ID: 6086944
[TBL] [Abstract][Full Text] [Related]
31. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
Tornos ME; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
[TBL] [Abstract][Full Text] [Related]
33. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
34. CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement.
Cavun S; Savci V
Fundam Clin Pharmacol; 2004 Oct; 18(5):513-23. PubMed ID: 15482372
[TBL] [Abstract][Full Text] [Related]
35. Acrylamide neurotoxicity.
Food Chem Toxicol; 1984 Jun; 22(6):489-90. PubMed ID: 6539742
[No Abstract] [Full Text] [Related]
36. CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers.
Dinsdale JR; Griffiths GK; Castelló J; Maddock J; Ortiz JA; Aylward M
Arzneimittelforschung; 1983; 33(7A):1061-5. PubMed ID: 6684468
[TBL] [Abstract][Full Text] [Related]
37. Studies on the intrathecal pharmacotherapy. Part I: CDP-choline.
Ogashiwa M; Takeuchi K; Hara M; Tanaka Y; Okada J
Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):327-35. PubMed ID: 1242132
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
Lozano Fernández R
Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
[TBL] [Abstract][Full Text] [Related]
39. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations.
Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
Auton Autacoid Pharmacol; 2008 Jan; 28(1):41-58. PubMed ID: 18257750
[TBL] [Abstract][Full Text] [Related]
40. Effects of cytidine 5'-diphosphocholine (CDP-choline) on the thermal nociceptive threshold in streptozotocin-induced diabetic mice.
Kamei J; Ohsawa M; Miyata S; Endo K; Hayakawa H
Eur J Pharmacol; 2008 Nov; 598(1-3):32-6. PubMed ID: 18834878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
